TALIMOGENE LAHERPAREPVEC for Product used for unknown indication: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 418 adverse event reports in the FDA FAERS database where TALIMOGENE LAHERPAREPVEC was used for Product used for unknown indication.
Most Reported Side Effects for TALIMOGENE LAHERPAREPVEC
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 196 | 13.3% | 25 | 25 |
| Pyrexia | 135 | 9.2% | 9 | 38 |
| Product storage error | 133 | 9.0% | 0 | 0 |
| Metastatic malignant melanoma | 109 | 7.4% | 42 | 10 |
| Circumstance or information capable of leading to medication error | 89 | 6.0% | 0 | 0 |
| Death | 82 | 5.6% | 82 | 9 |
| Influenza like illness | 82 | 5.6% | 6 | 14 |
| Fatigue | 70 | 4.8% | 6 | 12 |
| Chills | 68 | 4.6% | 3 | 13 |
| Malignant melanoma | 64 | 4.3% | 15 | 9 |
| Therapy partial responder | 56 | 3.8% | 12 | 5 |
| Therapy non-responder | 50 | 3.4% | 8 | 3 |
| Injection site pain | 47 | 3.2% | 3 | 5 |
| Oral herpes | 47 | 3.2% | 1 | 0 |
| Nausea | 46 | 3.1% | 6 | 9 |
Other Indications for TALIMOGENE LAHERPAREPVEC
Malignant melanoma (562)
Metastatic malignant melanoma (157)
Neuroendocrine carcinoma of the skin (37)
Melanoma recurrent (35)
Off label use (35)
Malignant melanoma stage iii (32)
Triple negative breast cancer (31)
Skin lesion (29)
Colorectal cancer (15)
Squamous cell carcinoma of skin (15)
Other Drugs Used for Product used for unknown indication
OXYCODONE (129,391)
ADAPALENE (91,681)
APIXABAN (88,417)
ETANERCEPT (71,866)
SACUBITRIL\VALSARTAN (69,693)
ACETAMINOPHEN (68,427)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (65,206)
ADALIMUMAB (63,549)
EVOLOCUMAB (60,696)
MORPHINE (59,440)